Digest Network Come funziona
Network
/
Società
PB
Non verificato

PBI-Gordon Companies, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaSaluteVetrine/Shopping

3 comunicati stampa

Guarda tutti i comunicati
10/09/2025
Biotecnologia
Farmaceutica
Industria
Animali
Salute
Vetrine/Shopping
Medicina - Varie
PBI-Gordon Companies, Inc. Delivers Record Growth and Investment in R&D as Multi-Year Strategic Plan Is Paying Off
Fonte
PBI-Gordon Companies, Inc.
Emittente
Business Wire
1.00
0
30/07/2025
Veterinaria
Igiene alimentare
Animali
Medicina - Varie
Cardiologia
Biotecnologia
Salute
Vetrine/Shopping
Farmaceutica
Industria
Felycin®-CA1 (Sirolimus Delayed-Release Tablets) is the First and Only Drug FDA Approved for the Management of Ventricular Hypertrophy in Cats with Subclinical Hypertrophic Cardiomyopathy (HCM), A Condition Affecting as Many as One in Seven Cats
Fonte
PBI-Gordon Companies, Inc.
Emittente
Business Wire
1.00
0
21/07/2025
Veterinaria
Salute
PBI-Gordon Companies, Inc. Calls on Petspan to Cease and Desist False and Misleading Advertisement, Promotion and Sale of Compounded Rapamycin (Sirolimus) for HCM in Cats
Fonte
PBI-Gordon Companies, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0